BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15356216)

  • 21. Antiallodynic effect of PhAR-DBH-Me involves cannabinoid and TRPV1 receptors.
    Quiñonez-Bastidas GN; Palomino-Hernández O; López-Ortíz M; Rocha-González HI; González-Anduaga GM; Regla I; Navarrete A
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00663. PubMed ID: 32965798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
    Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
    Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
    Lam PM; McDonald J; Lambert DG
    Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
    McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
    Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anandamide transport inhibition by the vanilloid agonist olvanil.
    Beltramo M; Piomelli D
    Eur J Pharmacol; 1999 Jan; 364(1):75-8. PubMed ID: 9920187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion neurons.
    Neelands TR; Jarvis MF; Faltynek CR; Surowy CS
    Inflamm Res; 2008 Sep; 57(9):404-9. PubMed ID: 18777111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives.
    Zhang X; Du XN; Zhang GH; Jia ZF; Chen XJ; Huang DY; Liu BY; Zhang HL
    Mol Pharmacol; 2012 May; 81(5):689-700. PubMed ID: 22328719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
    Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1.
    Zhang N; Inan S; Cowan A; Sun R; Wang JM; Rogers TJ; Caterina M; Oppenheim JJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4536-41. PubMed ID: 15764707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.
    Del Prete D; Caprioglio D; Appendino G; Minassi A; Schiano-Moriello A; Di Marzo V; De Petrocellis L
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1009-11. PubMed ID: 25666822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
    Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D
    Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
    Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
    J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL; Cichewicz DL; Welch SP
    Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
    El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.
    Avelino A; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):287-99. PubMed ID: 16721555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons.
    Mahmud A; Santha P; Paule CC; Nagy I
    Neuroscience; 2009 Sep; 162(4):1202-11. PubMed ID: 19463903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.